Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

PetVivo Holdings, Inc. (PETV)

2.56   0.06 (2.4%) 11-25 13:00
Open: 2.66 Pre. Close: 2.5
High: 2.66 Low: 2.5
Volume: 2,899 Market Cap: 26(M)

Technical analysis

as of: 2022-11-25 1:59:31 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 3.19     One year: 3.73
Support: Support1: 2.27    Support2: 1.99
Resistance: Resistance1: 2.73    Resistance2: 3.19
Pivot: 2.41
Moving Average: MA(5): 2.51     MA(20): 2.42
MA(100): 2.29     MA(250): 2.24
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 77.4     %D(3): 74.9
RSI: RSI(14): 54.8
52-week: High: 4.84  Low: 1.2
Average Vol(K): 3-Month: 18 (K)  10-Days: 12 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ PETV ] has closed below upper band by 21.0%. Bollinger Bands are 28.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.51 - 2.52 2.52 - 2.53
Low: 2.44 - 2.45 2.45 - 2.47
Close: 2.48 - 2.5 2.5 - 2.52

Company Description

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Headline News

Tue, 22 Nov 2022
Is PetVivo Holdings Inc (PETV) Stock About to Get Hot Tuesday? - InvestorsObserver

Wed, 16 Nov 2022
CORRECTION -- New to The Street / Newsmax TV Announces Nine Corporate Interviews on This Week's TV Broadcast, Sunday, November 13, 2022, Hour Slot 10-11 AM ET - Yahoo Finance

Sat, 12 Nov 2022
PetVivo Holdings, Inc. (PETV) Q2 2023 Earnings Call Transcript - Seeking Alpha

Fri, 11 Nov 2022
Should You Buy PetVivo Holdings Inc (PETV) Stock on Friday? - InvestorsObserver

Thu, 10 Nov 2022
New to The Street Announces its Five Business Guest Interviews on Episode #405, Airing on Bloomberg TV as a Sponsored Program, Tonight, November 10, 2022, at 9:30 PM PT - Yahoo Finance

Wed, 09 Nov 2022
PetVivo Holdings, Inc. to Exhibit at American Association of Equine Practitioners Conference in San Antonio, Texas - GlobeNewswire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. -4 (M)
Shares Float 0 (M)
% Held by Insiders 1.01e+007 (%)
% Held by Institutions 5.86e+006 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -85570
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.45
Profit Margin (%) 0
Operating Margin (%) -1
Return on Assets (ttm) 938.6
Return on Equity (ttm) -67.4
Qtrly Rev. Growth 387920
Gross Profit (p.s.) 495.52
Sales Per Share -102.64
EBITDA (p.s.) -44567.7
Qtrly Earnings Growth -7.42e+006
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value -5.77
Price to Sales -0.03
Price to Cash Flow 0

Stock Dividends

Dividend 163710
Forward Dividend 172440
Dividend Yield 6394920%
Dividend Pay Date 2020-12-29
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.